The company’s net income available to common shareholders reached $371 million, or $4.22 per share, a significant climb from the $318 million reported during the same period last year. This financial momentum was supported by a 9% year-over-year increase in net operating revenue, which landed well above the $5.47 billion consensus among analysts.

Segment Performance and Drivers

The ambulatory care division emerged as a primary growth engine, recording a 14% revenue increase. This surge was driven by strategic facility acquisitions and an expansion of specialized service lines. Meanwhile, hospital revenue grew by 7.3%, bolstered by a higher volume of patients with complex conditions and an increase in Medicaid supplemental revenue.

Management also provided a confident long-term outlook, guiding for 2026 net operating revenue between $21.5 billion and $22.3 billion. The company anticipates adjusted earnings for that period will range from $16.19 to $18.47 per share, aligning with or exceeding current analyst projections of $16.42.

Key performance indicators from the report include:

• Adjusted earnings of $4.70 per share against a $4.07 estimate.
• Ambulatory care revenue growth of 14% via facility acquisitions.
• Hospital segment revenue increase of 7.3% due to favorable payer mix.